Literature DB >> 9729575

Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model.

R M Winslow1, A Gonzales, M L Gonzales, M Magde, M McCarthy, R J Rohlfs, K D Vandegriff.   

Abstract

We have compared polyethylene glycol-modified bovine hemoglobin (PEG-Hb; high O2 affinity, high viscosity, high oncotic pressure) and human hemoglobin cross-linked between the alpha-chains (alpha alpha-Hb; low O2 affinity, low viscosity, low oncotic pressure) with a non-O2-carrying plasma expander (pentastarch, high viscosity and oncotic pressure) after a 50% (by volume) exchange transfusion followed by a severe (60% of blood volume) hemorrhage. Mean arterial pressure and systemic vascular resistance rose significantly in the alpha alpha-Hb but not in the PEG-Hb animals. Two-hour survival was greater in the PEG-Hb animals (93%) than in control (35%), pentastarch (8%), or alpha alpha-Hb (6%) animals. In the PEG-Hb animals, there was no disturbance of acid-base balance, significantly less accumulation of lactic acid, and higher cardiac output than in the other groups. The data suggest that the rise in vascular resistance that follows alpha alpha-Hb exchange transfusion offsets the additional O2 transport provided by the cell-free hemoglobin. When resistance does not rise, as with PEG-Hb, even relatively small amounts of cell-free hemoglobin appear to be a very effective blood replacement.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729575     DOI: 10.1152/jappl.1998.85.3.993

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

1.  Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate.

Authors:  Tao Hu; Muthuchidambaram Prabhakaran; Seetharama A Acharya; Belur N Manjula
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

Review 2.  [Treatment of hemorrhagic shock. New therapy options].

Authors:  W G Voelckel; A von Goedecke; D Fries; A C Krismer; V Wenzel; K H Lindner
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

3.  Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation.

Authors:  Dongxia Li; Belur N Manjula; A Seetharama Acharya
Journal:  Protein J       Date:  2006-06       Impact factor: 2.371

Review 4.  Blood substitutes: why haven't we been more successful?

Authors:  Abdu I Alayash
Journal:  Trends Biotechnol       Date:  2014-03-12       Impact factor: 19.536

5.  Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model.

Authors:  Bjorn Kyungsuck Song; William H Nugent; Paula F Moon-Massat; Roland N Pittman
Journal:  Microvasc Res       Date:  2014-07-18       Impact factor: 3.514

6.  Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin.

Authors:  Tao Hu; Belur N Manjula; Dongxia Li; Michael Brenowitz; Seetharama A Acharya
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

7.  Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function.

Authors:  Belur N Manjula; Amy G Tsai; Marcos Intaglietta; Ching-Hsuan Tsai; Chien Ho; Paul K Smith; Krishnaveni Perumalsamy; Nirmala Devi Kanika; Joel M Friedman; Seetharama A Acharya
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

8.  Combining the influence of two low O2 affinity-inducing chemical modifications of the central cavity of hemoglobin.

Authors:  Parimala Nacharaju; Joel M Friedman; Muthuchidambaram Prabhakaran; Seetharama A Acharya; Belur N Manjula
Journal:  Biochemistry       Date:  2007-03-24       Impact factor: 3.162

9.  Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock.

Authors:  Beatriz Y Salazar Vázquez; C Makena Hightower; Judith Martini; Catalina Messmer; Barbara Frienesenecker; Pedro Corbels; Amy G Tsai; Marcos Intaglietta
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

10.  Targeted O2 delivery by blood substitutes: in vitro arteriolar simulations of first- and second-generation products.

Authors:  Russell Cole; Kim Vandegriff; Andrew Szeri; Omer Savas; Robert Winslow
Journal:  Microvasc Res       Date:  2008-07-11       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.